decisionhealth Newsletters, Coder Pink Sheets - 2005 Issue 5 (May)
You may not know it, but . . .
Subscribe or sign in to view the full article.
Article Overview
This article covers a Medicare payment and pricing issue involving Part B drugs, with focus on physician reports of difficulty obtaining drugs at listed average sales price amounts and the agency’s response to possible pricing errors. It is relevant to physicians, practice managers, and medical coding or billing staff who follow Medicare drug reimbursement policy and related agency communications. The discussion also notes the role of specialty societies and regional Medicare contacts in reporting pricing problems.
Why This Topic Matters
Understanding Medicare drug pricing updates helps practices monitor reimbursement expectations, recognize when official price lists may be inaccurate, and follow current agency guidance affecting Part B drug billing and acquisition.
What You Will Learn
- The article’s focus on Medicare Part B drug pricing concerns
- How physician reports are being handled by the agency team referenced in the article
- The general role of practice reporting and specialty society involvement in price-list issues
- Why pricing accuracy matters for Medicare reimbursement and drug acquisition
Who Should Read This
- Physicians
- Medical practice managers
- Medical coders
- Medical billers
- Revenue cycle staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com